Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multimodal Dynamic Monitoring of Ocular Morphology Under Myopia Interventions
ChiCTR2600125362Phase 4Recruiting
- Sponsor
- The Second Xiangya Hospital
- Start
- May 2026
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of atropine in myopia (3 arms), sponsored by The Second Xiangya Hospital. Primary endpoint: Retinal curvature. Started May 2026; status: recruiting.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on ChiCTR2600125362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600125362.